论文部分内容阅读
目的:研究黄芪注射液联合二磷酸果糖治疗小儿病毒性心肌炎的疗效。方法:随机抽取病毒性心肌炎患儿120例,按照家长意愿分为研究组和对照组各60例。对照组采用常规方法治疗,研究组在对照组常规治疗的基础上加用黄芪注射液联合二磷酸果糖治疗。对比两组患儿治疗效果和实验室检查结果。结果:治疗2个疗程后,研究组总有效率为95.00%,对照组总有效率为83.33%,研究组总有效率高于对照组(P<0.05);治疗前两组CK、CK-MB及LDH差异不显著(P>0.05);治疗后两组实验室指标结果均低于治疗前(P<0.05),且研究组实验室检验指标结果均低于对照组,组间比较差异有统计学意义(P<0.05)。结论:使用黄芪注射液、二磷酸果糖联合治疗小儿病毒性心肌炎疗效显著,值得临床推广应用。
Objective: To study the therapeutic effect of Astragalus injection combined with fructose diphosphate on children with viral myocarditis. Methods: A total of 120 children with viral myocarditis were randomly selected and divided into study group and control group according to their wishes. The control group was treated by conventional method. The study group was treated with astragalus injection combined with fructose diphosphate on the basis of routine treatment in the control group. Comparison of two groups of children with treatment and laboratory test results. Results: After two courses of treatment, the total effective rate was 95.00% in the study group and 83.33% in the control group. The total effective rate in the study group was higher than that in the control group (P <0.05) (P <0.05). After treatment, the results of laboratory indexes in both groups were lower than those before treatment (P <0.05), and the results of laboratory test in the study group were lower than those in the control group Significance (P <0.05). Conclusion: Astragalus injection and fructose diphosphate combined treatment of children with viral myocarditis significant effect, worthy of clinical application.